Unknown

Dataset Information

0

Rho GDP-dissociation inhibitor ? is a potential prognostic biomarker and controls telomere regulation in colorectal cancer.


ABSTRACT: Rho GDP-dissociation inhibitor ? (RhoGDI?) is an essential regulator for Rho GTPases. Although RhoGDI? may serve as an oncogene in colorectal cancer (CRC), the underlying mechanism is still unclear. We investigated the function, mechanism, and clinical significance of RhoGDI? in CRC progression. We founded that downregulation of RhoGDI? repressed CRC cell proliferation, motility, and invasion. Overexpression of RhoGDI? increased DNA damage response signals at telomeres, and led to telomere shortening in CRC cells, also being validated in 26 pairs of CRC tissues. Mechanistic studies revealed that RhoGDI? could promote telomeric repeat factor 1 (TRF1) expression through the phosphatidylinositol 3-kinase-protein kinase B signal pathway. Moreover, RhoGDI? protein levels were strongly correlated with TRF1 in CRC tissues. A cohort of 297 CRC samples validated the positive relationship between RhoGDI? and TRF1, and revealed that RhoGDI? and TRF1 levels were negatively associated with CRC patients' survival. Taken together, our results suggest that RhoGDI? regulate TRF1 and telomere length and may be novel prognostic biomarkers in colorectal cancer.

SUBMITTER: Huang D 

PROVIDER: S-EPMC5497806 | biostudies-other | 2017 Jul

REPOSITORIES: biostudies-other

altmetric image

Publications

Rho GDP-dissociation inhibitor α is a potential prognostic biomarker and controls telomere regulation in colorectal cancer.

Huang Dandan D   Lu Weisi W   Zou Shaomin S   Wang Huaiming H   Jiang Yuanling Y   Zhang Xiya X   Li Pengqing P   Songyang Zhou Z   Wang Lei L   Wang Jianping J   Huang Junjiu J   Fang Lekun L  

Cancer science 20170531 7


Rho GDP-dissociation inhibitor α (RhoGDIα) is an essential regulator for Rho GTPases. Although RhoGDIα may serve as an oncogene in colorectal cancer (CRC), the underlying mechanism is still unclear. We investigated the function, mechanism, and clinical significance of RhoGDIα in CRC progression. We founded that downregulation of RhoGDIα repressed CRC cell proliferation, motility, and invasion. Overexpression of RhoGDIα increased DNA damage response signals at telomeres, and led to telomere short  ...[more]

Similar Datasets

| S-EPMC4556268 | biostudies-literature
| S-EPMC2701105 | biostudies-literature
| S-EPMC2583580 | biostudies-literature
| S-EPMC2364637 | biostudies-literature
| S-EPMC4450061 | biostudies-literature
| S-EPMC20713 | biostudies-literature
| S-EPMC2362126 | biostudies-literature
| S-EPMC3554444 | biostudies-literature
| S-EPMC5698060 | biostudies-literature
| S-EPMC3742540 | biostudies-literature